Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy International Prognostic Factors Study Group Journal of Clinical Oncology 28 (33), 4906-4911, 2010 | 308 | 2010 |
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase … S Siena, L Crino, M Danova, S Del Prete, S Cascinu, S Salvagni, ... Annals of oncology 21 (3), 655-661, 2010 | 120 | 2010 |
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results S Secondino, M Zecca, L Licitra, A Gurrado, I Schiavetto, P Bossi, L Locati, ... Annals of oncology 23 (2), 435-441, 2012 | 76 | 2012 |
Treatment of metastatic neuroendocrine carcinomas based on WHO classification S Artale, L Giannetta, G Cerea, D Maggioni, P Pedrazzoli, I Schiavetto, ... Anticancer research 25 (6C), 4463-4469, 2005 | 46 | 2005 |
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor D Montagna, I Turin, R Schiavo, E Montini, N Zaffaroni, R Villa, ... Cytotherapy 14 (1), 80-90, 2012 | 40 | 2012 |
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label … S Pignata, G Scambia, C Schettino, L Arenare, C Pisano, D Lombardi, ... The Lancet Oncology 24 (3), 286-296, 2023 | 29 | 2023 |
A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients … J Liu, IL Ray-Coquard, F Selle, A Poveda, D Cibula, HW Hirte, ... Journal of Clinical Oncology 32 (15_suppl), 5519-5519, 2014 | 26 | 2014 |
Cetuximab for treatment of metastatic colorectal cancer G Cerea, R Ricotta, I Schiavetto, MR Maugeri, A Sartore-Bianchi, ... Annals of Oncology 17, vii66-vii67, 2006 | 23 | 2006 |
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian … A Necchi, L Mariani, M Di Nicola, SL Vullo, N Nicolai, P Giannatempo, ... Annals of Oncology 26 (1), 167-172, 2015 | 21 | 2015 |
Pooled analysis of clinical outcome of patients with chemorefractory metastatic colorectal cancer treated within phase I/II clinical studies based on individual biomarkers of … A Sartore-Bianchi, A Amatu, E Bonazzina, S Stabile, L Giannetta, G Cerea, ... Targeted oncology 12, 525-533, 2017 | 16 | 2017 |
Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma S Secondino, P Pedrazzoli, I Schiavetto, V Basilico, E Bramerio, ... Bone marrow transplantation 42 (2), 131-133, 2008 | 9 | 2008 |
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer A Sartore-Bianchi, G Cerea, I Schiavetto, L Giannetta, R Ricotta, ... Annals of oncology 17, ii49-ii51, 2006 | 8 | 2006 |
Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia R Ricotta, G Cerea, I Schiavetto, MR Maugeri, P Pedrazzoli, S Siena Future Oncology 2 (6), 667-676, 2006 | 4 | 2006 |
Iron supplementation during treatment with erythropoiesis-stimulating agents for cancer-related anemia I Schiavetto, P Pedrazzoli, V Basilico, S Siena Chemotherapy 54 (6), 417-420, 2008 | 3 | 2008 |
Evidence of graft-versus-tumour effect following allogeneic haematopoietic stem cell transplantation in renal cancer other than clear cell type S Secondino, P Pedrazzoli, L Giannetta, I Schiavetto, A Vanzulli, S Siena Bone marrow transplantation 34 (10), 917-918, 2004 | 2 | 2004 |
Carboplatin/paclitaxel/darbepoetin α Anaemia and functional iron deficiency: case I Schiavetto Reactions 1306, 19, 2010 | | 2010 |
Cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharingeal carcinoma. P Comoli, S Secondino, LF Licitra, R Schiavo, I Schiavetto, A Gurrado, ... Journal of Clinical Oncology 28 (15_suppl), 2509-2509, 2010 | | 2010 |
T-cell therapy with anti-tumour cytotoxic T-cell lines in a patient with metastatic renal cell carcinoma D Montagna, P Pedrazzoli, I Turin, R Schiavo, E Montini, C Tullio, ... BONE MARROW TRANSPLANTATION 45, S177-S177, 2010 | | 2010 |
Cell therapy with autologous EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma P Comoli, P Pedrazzoli, L Licitra, S Secondino, A Gurrado, R Schiavo, ... BONE MARROW TRANSPLANTATION 45, S30-S31, 2010 | | 2010 |
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma S Secondino, S Basso, P Pedrazzoli, P Bossi, M Labirio, V Basilico, ... JOURNAL OF IMMUNOTHERAPY 30 (8), 860-861, 2007 | | 2007 |